Targeted Prostate Biopsy: How, When, and Why? A Systematic Review
Diagnostics · 26.08.2024 · 14 (17) · 1864
DOI: 10.3390/diagnostics14171864 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 26.08.2024. Verfasst von Giacomo Rebez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Urology Unit, Dipartimento Chirurgico Area Isontina, Azienda Sanitaria Universitaria Giuliano Isontina, 34170 Gorizia, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Prostate cancer, the second most diagnosed cancer among men, requires precise diagnostic techniques to ensure effective treatment. This review explores the technological advancements, optimal application conditions, and benefits of targeted prostate biopsies facilitated by multiparametric magnetic resonance imaging (mpMRI).
Methods
A systematic literature review was conducted to compare traditional 12-core systematic biopsies guided by transrectal ultrasound with targeted biopsy techniques using mpMRI. We searched electronic databases including PubMed, Scopus, and Web of Science from January 2015 to December 2024 using keywords such as “targeted prostate biopsy”, “fusion prostate biopsy”, “cognitive prostate biopsy”, “MRI-guided biopsy”, and “transrectal ultrasound prostate biopsy”. Studies comparing various biopsy methods were included, and data extraction focused on study characteristics, patient demographics, biopsy techniques, diagnostic outcomes, and complications. Conclusion: mpMRI-guided targeted biopsies enhance the detection of clinically significant prostate cancer while reducing unnecessary biopsies and the detection of insignificant cancers. These targeted approaches preserve or improve diagnostic accuracy and patient outcomes, minimizing the risks associated with overdiagnosis and overtreatment. By utilizing mpMRI, targeted biopsies allow for precise targeting of suspicious regions within the prostate, providing a cost-effective method that reduces the number of biopsies performed. This review highlights the importance of integrating advanced imaging techniques into prostate cancer diagnosis to improve patient outcomes and quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Urology Unit, Dipartimento Chirurgico Area Isontina, Azienda Sanitaria Universitaria Giuliano Isontina, 34170 Gorizia, Italy.
- Department of Medical, Surgical and Health Science, Urology Clinic, University of Trieste, 34100 Trieste, Italy.
- Medical School, University of Genoa, 16100 Genoa, Italy.
- Department of Urology, University of L'Aquila, 67100 L'Aquila, Italy.
- Urology Clinic, Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, 90127 Palermo, Italy.
ORCID-Profile: Giacomo Rebez, Franco Alchiede Simonato, Francesco Claps, Alchiede Simonato, Nicola Pavan
Zitieren
APA
Rebez, G., Barbiero, M., Simonato, F. A., Claps, F., Siracusano, S., Giaimo, R., Tulone, G., Vianello, F., Simonato, A., & Pavan, N. (2024). Targeted Prostate Biopsy: How, When, and Why? A Systematic Review. Diagnostics, 14(17), 1864. https://doi.org/10.3390/diagnostics14171864
Vancouver
Rebez G, Barbiero M, Simonato FA, Claps F, Siracusano S, Giaimo R, et al. Targeted Prostate Biopsy: How, When, and Why? A Systematic Review. Diagnostics. 2024;14(17):1864. doi:10.3390/diagnostics14171864
BibTeX
@article{Rebez2024,
author = {Rebez, Giacomo and Barbiero, Maria and Simonato, Franco Alchiede and Claps, Francesco and Siracusano, Salvatore and Giaimo, Rosa and Tulone, Gabriele and Vianello, Fabio and Simonato, Alchiede and Pavan, Nicola},
title = {Targeted Prostate Biopsy: How, When, and Why? A Systematic Review},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {17},
pages = {1864},
doi = {10.3390/diagnostics14171864}
}
EUVIMED